Viewing Study NCT04393350


Ignite Creation Date: 2025-12-24 @ 4:57 PM
Ignite Modification Date: 2025-12-25 @ 2:39 PM
Study NCT ID: NCT04393350
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-02-26
First Post: 2020-05-14
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Perioperative Lenvatinib With Pembrolizumab in Patients With Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma
Sponsor: Emory University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module